Todas las investigaciones
AutorizadoPhase I and Phase II (Integrated)- OtherIntervencionista

CAT-01

The CAT-01 trial is an important research study for women diagnosed with cervical cancer. It's an early-stage trial, which means researchers are carefully testing a new treatment for the first time in people. The main goals are to make sure the treatment is safe and to see if it has a positive effect on the cancer. This study is open to women who are 18 years old or older. Taking part in a trial like this can help doctors learn more about new ways to fight cervical cancer, potentially leading to better treatments in the future for many women. It's a key part of developing new medicines.

De un vistazo

Estado
Autorizado
Fase
Phase I and Phase II (Integrated)- Other
Patrocinador
Karolinska Institutet
Objetivo de inscripción
20
Inicio
09 Mar 2026

¿De qué trata este estudio?

This research study, known as CAT-01, is focused on exploring new treatments for cervical cancer. Cervical cancer is a type of cancer that starts in the cervix, which is the lower part of the womb. Scientists and doctors are always working hard to find better and safer ways to treat this condition, and studies like CAT-01 are a crucial step in that process.

This particular study is in its early stages, often called Phase I and Phase II. This means that researchers are carefully giving a new treatment to people for the first time. The very first priority is to check how safe the new treatment is and what kind of side effects it might cause. Once they understand the safety, they also start to look at whether the treatment is showing any signs of helping the body fight the cancer.

By taking part in studies like CAT-01, volunteers play a vital role in medical progress. Their involvement helps researchers gather important information that can lead to the development of new and more effective medicines or therapies for cervical cancer. This ultimately benefits not just the participants, but also future patients around the world.

Puntos clave

  • This study is testing a new treatment for cervical cancer.
  • It's an early-stage trial (Phase I/II) focusing on safety and initial effectiveness.
  • Only women aged 18 or older with cervical cancer can consider joining.
  • La participación implica un seguimiento cercano por parte de un equipo médico.
  • You can withdraw from the study at any point.
  • Your involvement helps advance cancer research.

¿Quién puede ser elegible?

To be considered for the CAT-01 study, you need to be a woman who has been diagnosed with cervical cancer. The study is open to adults, meaning you must be at least 18 years old.

There might be other specific health requirements or conditions that you need to meet to join. These are put in place to ensure your safety during the study and to make sure the researchers can effectively learn from the results.

Your doctor will be able to go through all the detailed requirements with you to see if this study could be a suitable option.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. Are you a woman?
  2. Have you been diagnosed with cervical cancer?
  3. ¿Tienes 18 años o más?
  4. Are you able to attend appointments regularly if required?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

The details of what taking part involves aren't fully described here, but generally, in an early-stage study like this, you would have regular visits to the clinic or hospital. These visits are important for the medical team to monitor your health closely and see how you are responding to the study treatment. This might include various tests, such as blood tests, scans, and physical examinations. You would receive the study medication as prescribed by the research team.

There would also be follow-up appointments after you finish the main treatment part of the study to continue monitoring your health and any long-term effects. The total length of your participation, including treatment and follow-up, would be clearly explained to you before you agree to join.

Riesgos y beneficios potenciales

Taking part in a clinical trial may offer potential benefits, such as access to a new treatment before it's widely available. It also contributes to medical knowledge, which can help others in the future. However, there are also potential risks; new treatments can have side effects, and it's possible the new treatment may not work for everyone. Before joining, the study team will explain all known risks and discomforts. Remember, you have the right to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Ubicaciones (1)

Algunas ubicaciones de los sitios son aproximadas. Estamos mejorando esto — por favor verifique con el equipo de prueba antes de viajar.
  • —
    No verificado
    Suecia

Preguntas comunes

¿Qué es el cáncer de cuello uterino?

Cervical cancer is a type of cancer that starts in the cervix, which is the lower part of the womb (uterus) that connects to the vagina.

What does 'Phase I and Phase II' mean?

These are early stages of clinical research. Phase I mainly checks if a new treatment is safe. Phase II looks at safety again, and also if the treatment shows signs of working.

Will I get the new treatment if I join?

If you are eligible and decide to join this study, you would receive the new treatment being tested, rather than a placebo or standard treatment, as this is how early-stage trials are designed.

¿Quién puede unirse a este estudio?

This study is open to women aged 18 and over who have been diagnosed with cervical cancer. There are other specific health checks to ensure your safety and suitability.

¿Qué pasa si cambio de opinión sobre participar?

You are free to leave the study at any time, for any reason, and this will not affect your ongoing medical care.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.